0A7B Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Chimera Investment Corp

Watchlist Manager

Watchlist

Price: 10.905 USD -2.2% Market Closed

Market Cap: $906.8m

	Chimera Investment Corp LSE:0A7B	US
	Akari Therapeutics PLC NASDAQ:AKTX	US
M	MillerKnoll Inc NASDAQ:MLKN	US
F	FirstService Corp NASDAQ:FSV	CA
	Arlo Technologies Inc NYSE:ARLO	US
	Haseko Corp OTC:HSKCF	JP
A	AstraZeneca PLC F:ZEG	UK
	Zebra Technologies Corp NASDAQ:ZBRA	US
D	DXC Technology Co SWB:2XT	US
	Arbor Realty Trust Inc NYSE:ABR	US

Profitability Summary

Chimera Investment Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

32%

Sustainable 3Y Average Gross Margin

30%

Gross Margin is Increasing

28% > 32%

Healthy Operating Margin

13%

Sustainable 3Y Average Operating Margin

18%

Operating Margin is Increasing

13% > 13%

Negative Net Margin

-10%

Sustainable 3Y Average Net Margin

11%

Net Margin is Increasing

-11% > -10%

Negative Free Cash Flow Margin

-45%

Sustainable 3Y Average Free Cash Flow Margin

10%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.